ArticleAnnals of surgical oncology2026
Assessing Recent Trends in Lumpectomy and Concomitant Oncoplastic Procedures: A National Insurance Database Analysis.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- ASO Author Reflections: Redefining Breast-Conserving Therapy: National Trends in Oncoplastic Reconstruction.Annals of surgical oncology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFollowing the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-06 trial, breast-conserving therapy (BCT) has increasingly replaced mastectomy for eligible patients. Concurrently, oncoplastic surgical techniques have evolved to address contour deformities associated with lumpectomy and adjuvant radiation. While utilization of BCT has been well described, national trends in oncoplastic reconstruction remain less well defined. This study evaluates temporal trends in post-lumpectomy reconstruction using a large national insurance database. PATIENTS AND
methodsThe PearlDiver™ national claims database was queried for patients undergoing lumpectomy (Current Procedural Terminology (CPT) 19301) from 2010 to 2020. Patients were stratified into four cohorts: lumpectomy alone, lumpectomy with mastopexy (LM; CPT 19316), lumpectomy with reduction mammaplasty (LR; CPT 19318), and lumpectomy with adjacent tissue rearrangement (LATR; CPT 14301/14302/19366). Primary outcomes included annual procedural volumes and proportional trends. Associations with demographics, comorbidities, and insurance status were analyzed using Welch's analysis of variance (ANOVA) and chi-squared testing.
resultsAmong 486,368 patients, 92.3% underwent lumpectomy alone, while 4.6% underwent LATR, 1.6% LR, and 1.0% LM. Mean age differed significantly across cohorts (p < 0.001), with LR patients being youngest. Overall lumpectomy volume increased 27% over the decade, while lumpectomy with reconstruction increased 249%, driven by a 250% increase in LATR and a 622% increase in LR. Comorbidity burden was highest in the lumpectomy-alone cohort, whereas obesity and tobacco use were more prevalent in LR patients. Insurance distribution differed among groups (p < 0.001).
conclusionsOncoplastic reconstruction following lumpectomy has increased from 2010 to 2020, led by adjacent tissue rearrangement techniques. These trends reflect an expanding emphasis on aesthetic and quality-of-life outcomes in breast-conserving therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.